☰ Navigation Tabs
Crystal structure of the therapeutic antibody binding fragment of gevokizumab in its unbound state External Resource: Annotation Chains Family Name Domain Identifier Architecture Possible Homology Homology Topology Family Provenance Source (Version) B [auth L] 14-3-3 e4g6kL1 A: alpha arrays X: beta-Grasp H: Ubiquitin-related T: Ubiquitin-like F: 14-3-3 ECOD (v295.2) A [auth H] Prenyltransf e4g6kH1 A: alpha arrays X: GIY-YIG endonuclease H: GIY-YIG endonuclease T: GIY-YIG endonuclease F: Prenyltransf ECOD (v295.2)
Chain Protein Name Description Organism Name Gene Allele Name(s) Domain Name(s) Receptor Type Receptor Description Provenance Source B [auth L] G1-derived gevokizumab Fab L-KAPPA Humanized, Chimeric IGKV1D-7-1*01, IGKJ2*01, IGKJ2*02, IGKC*01 V-DOMAIN V-KAPPA, C-DOMAIN C-KAPPA IG FAB-GAMMA-1_KAPPA IMGT (202637-0) A [auth H] G1-derived gevokizumab Fab VH-CH1 Humanized, Chimeric IGHV8-4-12*01, IGHV8-4-8*01, IGHJ4*01, IGHG1*03, IGHG1*08, IGHG1*06, IGHG1*17 V-DOMAIN VH, C-DOMAIN CH1 IG FAB-GAMMA-1_KAPPA IMGT (202637-0)
Chain Chain Class Chain Subclass Chain Type Antigen Name(s) Provenance Source B [auth L] Light Chain IGKV1 Kappa - SAbDab (2026-09-25) A [auth H] Heavy Chain IGHV4 - - SAbDab (2026-09-25)